Skip to main navigation menu Skip to main content Skip to site footer

Review article: Biomedical intelligence

Vol. 147 No. 3940 (2017)

Challenges of congenital heart disease in grown-up patients

  • Markus Schwerzmann
  • Fabienne Schwitz
  • Corina Thomet
  • Alexander Kadner
  • Jean-Pierre Pfammatter
  • Kerstin Wustmann
DOI
https://doi.org/10.4414/smw.2017.14495
Cite this as:
Swiss Med Wkly. 2017;147:w14495
Published
30.09.2017

Summary

Nowadays, more than 90% of all children born with congenital heart disease (CHD) reach adult life. Although initially considered to be cured, the majority of them continue to need specialised follow-up because they require re-do interventions or are at increased risk of cardiovascular complications and premature death. Arrhythmias are the most common cause of unscheduled hospital visits for grown-up CHD (GUCH) patients, accounting for one third of emergency admissions in these patients. Some GUCH patients are also at increased risk for sudden cardiac death. The principles of arrhythmia management and the prevention of sudden cardiac death in GUCH patients are similar to those used in adults with acquired heart disease, but are not evidence based. Decompensated heart failure is the other leading cause of death. Conventional medical heart-failure therapy for left ventricular dysfunction is not effective in GUCH patients at highest risk of heart failure, i.e., those with right or single ventricular failure. Careful haemodynamic assessment and structural interventions are the first step to consider in GUCH patients presenting with heart failure symptoms. Adults with moderate or complex CHD and regular follow-up in specialised GUCH centres have a survival benefit compared with patients without such follow-up. Cardiac surgery in GUCH patients should be performed by surgeons trained in treatment of CHD, i.e., surgeons also operating on paediatric patients. A structured transition programme with a defined transfer of care from the paediatric to the adult care environment is important to avoid lapses of care in today’s adolescents with CHD. For GUCH patients with an intervention performed decades ago and no specific cardiac follow-up in later life, referral to a specialised GUCH centre is recommended and may save lives.

References

  1. Dolk H, Loane M, Garne E ; European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123(8):841–9. doi:.https://doi.org/10.1161/CIRCULATIONAHA.110.958405
  2. Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264–72. doi:.https://doi.org/10.1161/CIRCULATIONAHA.110.946343
  3. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56. doi:.https://doi.org/10.1161/CIRCULATIONAHA.113.008396
  4. Baumgartner H, Budts W, Chessa M, Deanfield J, Eicken A, Holm J, et al.; Working Group on Grown-up Congenital Heart Disease of the European Society of Cardiology. Recommendations for organization of care for adults with congenital heart disease and for training in the subspecialty of ‘Grown-up Congenital Heart Disease’ in Europe: a position paper of the Working Group on Grown-up Congenital Heart Disease of the European Society of Cardiology. Eur Heart J. 2014;35(11):686–90. doi:.https://doi.org/10.1093/eurheartj/eht572
  5. Baum VC. Pediatric cardiac surgery: an historical appreciation. Paediatr Anaesth. 2006;16(12):1213–25. doi:.https://doi.org/10.1111/j.1460-9592.2006.02029.x
  6. The surgical treatment of tetralogy of Fallot. Dis Chest. 1958;34(1):103–9.
  7. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240–8. doi:.https://doi.org/10.1136/thx.26.3.240
  8. Jortveit J, Øyen N, Leirgul E, Fomina T, Tell GS, Vollset SE, et al. Trends in Mortality of Congenital Heart Defects. Congenit Heart Dis. 2016;11(2):160–8. doi:.https://doi.org/10.1111/chd.12307
  9. Warnes CA, Liberthson R, Danielson GK, Jr, Dore A, Harris L, Hoffman JIE, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37(5):1170–5. doi:.https://doi.org/10.1016/S0735-1097(01)01272-4
  10. Warnes CA. Adult congenital heart disease: the challenges of a lifetime. Eur Heart J. 2016 Dec 23:ehw529. [Epub ahead of print] doi:.https://doi.org/10.1093/eurheartj/ehw529
  11. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54(5):460–7. doi:.https://doi.org/10.1016/j.jacc.2009.04.037
  12. Padrutt M, Bracher I, Bonassin F, Santos Lopes B, Gruner C, Stämpfli SF, et al. Impact of growing cohorts of adults with con-genital heart disease on clinical workload: a 20-year experience at a tertiary care centre. Swiss Med Wkly. 2017;147:w14443. doi:.https://doi.org/10.4414/smw.2017.14443
  13. Cedars AM, Burns S, Novak EL, Amin AP. Predictors of Rehospitalization Among Adults With Congenital Heart Disease Are Lesion Specific. Circ Cardiovasc Qual Outcomes. 2016;9(5):566–75. doi:.https://doi.org/10.1161/CIRCOUTCOMES.116.002733
  14. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda GT, et al. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010;96(11):872–8. doi:.https://doi.org/10.1136/hrt.2009.185595
  15. Tutarel O. Acquired heart conditions in adults with congenital heart disease: a growing problem. Heart. 2014;100(17):1317–21. doi:.https://doi.org/10.1136/heartjnl-2014-305575
  16. Wang A, Book WM, McConnell M, Lyle T, Rodby K, Mahle WT. Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992. Am J Cardiol. 2007;100(8):1307–9. doi:.https://doi.org/10.1016/j.amjcard.2007.05.059
  17. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008;118(23):e714–833. doi:.https://doi.org/10.1161/CIRCULATIONAHA.108.190690
  18. Bouchardy J, Greutmann M, Schwerzmann M, Attenhofer Jost CH, De Pasquale G, Oxenius A, et al. Grown-up Congenital Heart Disease (GUCH) Recommendations for Standards of Care. Cardiovasc Med. 2015;18(4):144–5. doi:.https://doi.org/10.4414/cvm.2015.00317
  19. Mylotte D, Pilote L, Ionescu-Ittu R, Abrahamowicz M, Khairy P, Therrien J, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129(18):1804–12. doi:.https://doi.org/10.1161/CIRCULATIONAHA.113.005817
  20. Karamlou T, Diggs BS, Person T, Ungerleider RM, Welke KF. National practice patterns for management of adult congenital heart disease: operation by pediatric heart surgeons decreases in-hospital death. Circulation. 2008;118(23):2345–52. doi:.https://doi.org/10.1161/CIRCULATIONAHA.108.776963
  21. Vouhé PR. Adult congenital surgery: current management. Semin Thorac Cardiovasc Surg. 2011;23(3):209–15. doi:.https://doi.org/10.1053/j.semtcvs.2011.09.003
  22. Fuller SM, He X, Jacobs JP, Pasquali SK, Gaynor JW, Mascio CE, et al. Estimating Mortality Risk for Adult Congenital Heart Surgery: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database. Ann Thorac Surg. 2015;100(5):1728–35, discussion 1735–6. doi:.https://doi.org/10.1016/j.athoracsur.2015.07.002
  23. Kovacs AH, McCrindle BW. So hard to say goodbye: transition from paediatric to adult cardiology care. Nat Rev Cardiol. 2014;11(1):51–62. doi:.https://doi.org/10.1038/nrcardio.2013.172
  24. Goossens E, Stephani I, Hilderson D, Gewillig M, Budts W, Van Deyk K, et al.; SWITCH(2) Investigators. Transfer of adolescents with congenital heart disease from pediatric cardiology to adult health care: an analysis of transfer destinations. J Am Coll Cardiol. 2011;57(23):2368–74. doi:.https://doi.org/10.1016/j.jacc.2010.11.068
  25. Yeung E, Kay J, Roosevelt GE, Brandon M, Yetman AT. Lapse of care as a predictor for morbidity in adults with congenital heart disease. Int J Cardiol. 2008;125(1):62–5. doi:.https://doi.org/10.1016/j.ijcard.2007.02.023
  26. Schwerzmann M. Congenital heart disease clinics - how to keep the adult patients on board. Prog Pediatr Cardiol. 2012;34(2):113–7. doi:.https://doi.org/10.1016/j.ppedcard.2012.08.010
  27. Sable C, Foster E, Uzark K, Bjornsen K, Canobbio MM, Connolly HM, et al.; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation. 2011;123(13):1454–85. doi:.https://doi.org/10.1161/CIR.0b013e3182107c56
  28. Mackie AS, Islam S, Magill-Evans J, Rankin KN, Robert C, Schuh M, et al. Healthcare transition for youth with heart disease: a clinical trial. Heart. 2014;100(14):1113–8. doi:.https://doi.org/10.1136/heartjnl-2014-305748
  29. Goossens E, Fieuws S, Van Deyk K, Luyckx K, Gewillig M, Budts W, et al. Effectiveness of structured education on knowledge and health behaviors in patients with congenital heart disease. J Pediatr. 2015;166(6):1370–6.e1. doi:.https://doi.org/10.1016/j.jpeds.2015.02.041
  30. Bouchardy J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Bottega N, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120(17):1679–86. doi:.https://doi.org/10.1161/CIRCULATIONAHA.109.866319
  31. Kaemmerer H, Bauer U, Pensl U, Oechslin E, Gravenhorst V, Franke A, et al. Management of emergencies in adults with congenital cardiac disease. Am J Cardiol. 2008;101(4):521–5. doi:.https://doi.org/10.1016/j.amjcard.2007.09.110
  32. Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014;11(10):e102–65. doi:.https://doi.org/10.1016/j.hrthm.2014.05.009
  33. Lanz J, Brophy JM, Therrien J, Kaouache M, Guo L, Marelli AJ. Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors. Circulation. 2015;132(25):2385–94. doi:.https://doi.org/10.1161/CIRCULATIONAHA.115.011241
  34. Hoffmann A, Chockalingam P, Balint OH, Dadashev A, Dimopoulos K, Engel R, et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart. 2010;96(15):1223–6. doi:.https://doi.org/10.1136/hrt.2010.196147
  35. Khairy P, Aboulhosn J, Broberg CS, Cohen S, Cook S, Dore A, et al.; Anticoagulation Therapy in Congenital Heart Disease (TACTIC) investigators and the Alliance for Adult Research in Congenital Cardiology (AARCC). Thromboprophylaxis for atrial arrhythmias in congenital heart disease: A multicenter study. Int J Cardiol. 2016;223:729–35. doi:.https://doi.org/10.1016/j.ijcard.2016.08.223
  36. Jensen AS, Idorn L, Nørager B, Vejlstrup N, Sondergaard L. Anticoagulation in adults with congenital heart disease: The who, the when and the how? Heart. 2015;101(6):424–9. doi:.https://doi.org/10.1136/heartjnl-2014-305576
  37. Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, et al. Sudden cardiac death in adult congenital heart disease. Circulation. 2012;126(16):1944–54. doi:.https://doi.org/10.1161/CIRCULATIONAHA.112.104786
  38. Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol. 2014;30(10):e1–63. doi:.https://doi.org/10.1016/j.cjca.2014.09.002
  39. Schwerzmann M, Salehian O, Harris L, Siu SC, Williams WG, Webb GD, et al. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Eur Heart J. 2009;30(15):1873–9. doi:.https://doi.org/10.1093/eurheartj/ehp179
  40. Zomer AC, Vaartjes I, Uiterwaal CS, van der Velde ET, van den Merkhof LF, Baur LH, et al. Circumstances of death in adult congenital heart disease. Int J Cardiol. 2012;154(2):168–72. doi:.https://doi.org/10.1016/j.ijcard.2010.09.015
  41. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220–9. doi:.https://doi.org/10.1093/eurheartj/ehq032
  42. Krieger EV, Valente AM. Heart failure treatment in adults with congenital heart disease: where do we stand in 2014? Heart. 2014;100(17):1329–34. doi:.https://doi.org/10.1136/heartjnl-2014-305667
  43. Zomer AC, Vaartjes I, van der Velde ET, de Jong HM, Konings TC, Wagenaar LJ, et al. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol. 2013;168(3):2487–93. doi:.https://doi.org/10.1016/j.ijcard.2013.03.003
  44. Budts W, Roos-Hesselink J, Rädle-Hurst T, Eicken A, McDonagh TA, Lambrinou E, et al. Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2016;37(18):1419–27. doi:.https://doi.org/10.1093/eurheartj/ehv741
  45. McLarry J, Broberg C, Opotowsky AR, Kaufman T, Stout K, Burchill LJ. Defining heart failure in adult congenital heart disease. Prog Pediatr Cardiol. 2014;38(1-2):3–7. doi:https://doi.org/10.1016/j.ppedcard.2014.12.002
  46. Burchill LJ. Heart transplantation in adult congenital heart disease. Heart. 2016;102(23):1871–7. doi:.https://doi.org/10.1136/heartjnl-2015-309074
  47. Davies RR, Russo MJ, Yang J, Quaegebeur JM, Mosca RS, Chen JM. Listing and transplanting adults with congenital heart disease. Circulation. 2011;123(7):759–67. doi:.https://doi.org/10.1161/CIRCULATIONAHA.110.960260
  48. Loup O, Wustmann K, Martinelli MV, Schwerzmann M, Mohacsi P, Carrel TP, et al. Failing Systemic Right Ventricles With Persistent Pulmonary Hypertension: Candidates for Ventricular Assist Devices as Destination Therapy? Ann Thorac Surg. 2017;103(2):e179–81. doi:.https://doi.org/10.1016/j.athoracsur.2016.03.080
  49. Tobler D, Bouchardy J, Reto E, Heg D, Müller C, Frenk A, et al.; SERVE trial. Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and design. Int J Cardiol. 2017 May 23:S0167-5273(17)32122-8. [Epub ahead of print] doi:.https://doi.org/10.1016/j.ijcard.2017.05.079
  50. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al.; Document Reviewers. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128. doi:.https://doi.org/10.1093/eurheartj/ehv319
  51. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Veen G, et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J. 2011;32(15):1926–34. doi:.https://doi.org/10.1093/eurheartj/ehq485
  52. Kuijpers JM, Koolbergen DR, Groenink M, Peels KC, Reichert CL, Post MC, et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J. 2017 Jan 8:ehw591. [Epub ahead of print] doi:.https://doi.org/10.1093/eurheartj/ehw591
  53. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Vliegen HW, et al. Gender and outcome in adult congenital heart disease. Circulation. 2008;118(1):26–32. doi:.https://doi.org/10.1161/CIRCULATIONAHA.107.758086
  54. Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc. 2009;140(10):1238–44. doi:.https://doi.org/10.14219/jada.archive.2009.0046
  55. Stadelmann P, Zemp E, Weiss C, Weiger R, Menghini G, Zitzmann NU. Dental visits, oral hygiene behaviour, and orthodontic treatment in Switzerland. Schweiz Monatsschr Zahnmed. 2012;122(2):104–26.
  56. Schmidt S, Ramseier-Hadorn M, Thomet C, Wustmann K, Schwerzmann M. Gender-related differences in self-reported dental care in adults with congenital heart disease at increased risk of infective endocarditis. Open Heart. 2017;4(1):e000575. doi:.https://doi.org/10.1136/openhrt-2016-000575
  57. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al.; Document Reviewers. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128. doi:.https://doi.org/10.1093/eurheartj/ehv319
  58. Greutmann M, Pieper PG. Pregnancy in women with congenital heart disease. Eur Heart J. 2015;36(37):2491–9. doi:.https://doi.org/10.1093/eurheartj/ehv288
  59. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al.; European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM); ESC Committee for Practice Guidelines. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97. doi:.https://doi.org/10.1093/eurheartj/ehr218
  60. Houben CH, Spruit MA, Groenen MT, Wouters EF, Janssen DJ. Efficacy of advance care planning: a systematic review and meta-analysis. J Am Med Dir Assoc. 2014;15(7):477–89. doi:.https://doi.org/10.1016/j.jamda.2014.01.008
  61. Tobler D, Greutmann M, Colman JM, Greutmann-Yantiri M, Librach LS, Kovacs AH. End-of-life in adults with congenital heart disease: a call for early communication. Int J Cardiol. 2012;155(3):383–7. doi:.https://doi.org/10.1016/j.ijcard.2010.10.050
  62. Deng LX, Gleason LP, Khan AM, Drajpuch D, Fuller S, Goldberg LA, et al. Advance Care Planning in Adults with Congenital Heart Disease: A Patient Priority. Int J Cardiol. 2017;231:105–9. doi:.https://doi.org/10.1016/j.ijcard.2016.12.185
  63. Greutmann M, Tobler D, Colman JM, Greutmann-Yantiri M, Librach SL, Kovacs AH. Facilitators of and barriers to advance care planning in adult congenital heart disease. Congenit Heart Dis. 2013;8(4):281–8. Published online January 03, 2013. doi:.https://doi.org/10.1111/chd.12025

Most read articles by the same author(s)